Navigation

Follicular lymphoma - rituximab (review)

Rituximab for the treatment of follicular lymphoma (review of TA110)

Status: History
Expected date of issue: January 2012
Process: MTA
Topic area:
  • Cancer
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: Sally Doss
Communications manager: Katie Williamson
Project manager: Lori Farrar
Top


 

Provisional schedule

Information meeting with consultees: 12 November 2010
Closing date for invited submissions / evidence submission: 13 December 2010
Final scope published: September 2010
1st appraisal committee meeting: 11 August 2011
2nd appraisal committee meeting: 13 October 2011
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Roche Products (rituximab)

Patient/carer groups

  • Leukaemia CARE
  • Lymphoma Association
  • Macmillan Cancer Support

Professional groups

  • British Society for Haematology
  • Cancer Research UK
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians,

Others

  • Department of Health
  • North Tyneside PCT
  • Welsh Assembly Government

General

  • British National Formulary
  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Healthcare Improvement Scotland

Comparator manufacturers

  • None

Relevant research groups

  • Leukaemia and lymphoma Research

Assessment Team

  • National Institute for Health Research Health Technology Assessment Programme
  • School of Health & Related Research Sheffield

   

Top


 

Key documents

This page was last updated: 18 January 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.